4//SEC Filing
Morley Stephanie 4
Accession 0000905718-18-000403
CIK 0001684144other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 6:36 PM ET
Size
10.3 KB
Accession
0000905718-18-000403
Insider Transaction Report
Form 4
Morley Stephanie
COO & VP of Product Dev
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-04-20−104,000→ 0 totalExercise: $0.20From: 2016-03-28Exp: 2018-04-21→ Common Shares, without par value (104,000 underlying) - Exercise/Conversion
Common Shares, without par value
2018-04-20$0.20/sh+104,000$20,800→ 1,459,580 total
Holdings
- 1,000(indirect: By step-son)
Common Shares, without par value
- 1,000(indirect: By daughter)
Common Shares, without par value
- 1,000(indirect: By daughter)
Common Shares, without par value
- 1,000(indirect: By step-son)
Common Shares, without par value
- 1,000(indirect: By step-daughter)
Common Shares, without par value
Documents
Issuer
Zomedica Pharmaceuticals Corp.
CIK 0001684144
Entity typeother
Related Parties
1- filerCIK 0001721793
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 6:36 PM ET
- Size
- 10.3 KB